From: Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial
Variable | ICS group (n = 58) | Control group (n = 58) | P |
---|---|---|---|
Operation time, min | 113.52 ± 18.33 | 120.26 ± 27.55 | 0.937 |
Blood loss, ml | 2350.68 ± 600.52 | 2520.12 ± 610.77 | 0.986 |
Preoperative haemoglobin | 116.52 ± 41.35 | 115.47 ± 41.11 | 0.998 |
Intraoperative haemoglobin minimum | 66.85 ± 12.58 | 64.55 ± 15.63 | 0.807 |
Postoperative haemoglobin | 100.71 ± 37.33 | 96.15 ± 33.26 | 0.943 |
IOCS, mL | 735.67 ± 37.58 | N/A | N/A |
ABT, mL | 820.76 ± 185.93 | 1370.53 ± 200.65 | 3.6e− 5 |
Volume of crystalloid infusion, ml | 3800.69 ± 150.33 | 3850.57 ± 180.51 | 0.981 |
Volume of colloid infusion, ml | 500.38 ± 50.52 | 500.26 ± 60.73 | 1 |
Fibrinogen transfusion | 21(36.21%) | 20(34.48%) | 0.893 |
Platelet transfusion | 4(6.9%) | 3(5.17%) | 0.714 |